U.S. flag

An official website of the United States government

NM_021954.4(GJA3):c.-17-245_-17-235del AND not provided

Germline classification:
Likely benign (1 submission)
Last evaluated:
Oct 19, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002286106.2

Allele description [Variation Report for NM_021954.4(GJA3):c.-17-245_-17-235del]

NM_021954.4(GJA3):c.-17-245_-17-235del

Gene:
GJA3:gap junction protein alpha 3 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
13q12.11
Genomic location:
Preferred name:
NM_021954.4(GJA3):c.-17-245_-17-235del
HGVS:
  • NC_000013.11:g.20143540_20143550del
  • NG_016399.1:g.22495_22505del
  • NM_021954.4:c.-17-245_-17-235delMANE SELECT
  • NC_000013.10:g.20717679_20717689del
Molecular consequence:
  • NM_021954.4:c.-17-245_-17-235del - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: CN517202

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002575965GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Likely benign
(Oct 19, 2021)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From GeneDx, SCV002575965.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

See Variant Classification Assertion Criteria.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 4, 2023